Details of Research Outputs

TitleMicroRNA-483 amelioration of experimental pulmonary hypertension
Author (Name in English or Pinyin)
Zhang, J.1; He, Y.2; Yan, X.1; Chen, S.1; He, M.3; Lei, Y.1; Zhang, J.1,3,4; Gongol, B.3; Gu, M.5; Miao, Y.5; Bai, L.1; Cui, X.6; Wang, X.2; Zhang, Y.2; Fan, F.4; Li, Z.1; Shen, Y.7; Chou, C.-H.8; Huang, H.-D.9; Malhotra, A.3; Rabinovitch, M.5; Jing, Z.-C.10; Shyy, J.Y.J.1,3
Date Issued2020-04-23
Source PublicationEMBO Molecular Medicine
ISSN1757-4676
DOI10.15252/emmm.201911303
Firstlevel Discipline生物学
Education discipline科技类
Published range国外学术期刊
References
[1] Alastalo TP, Li M, Perez Vde J, Pham D, Sawada H, Wang JK, Koskenvuo M, Wang L, Freeman BA, Chang HY et al (2011) Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest 121: 3735–3746
Citation statistics
Cited Times:32[WOS]   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
Identifierhttps://irepository.cuhk.edu.cn/handle/3EPUXD0A/1294
CollectionSchool of Medicine
Arieh Warshel Institute for Computational Biology
Co-First AuthorHe, Y.
Corresponding AuthorJing, Z.-C.; Shyy, J.Y.J.
Affiliation
1.Cardiovascular Research Center, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education of China, Xi'an Jiaotong University, Xian, China
2.State Key Laboratory of Cardiovascular disease & FuWai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
3.Department of Medicine, University of California, San Diego, La Jolla, CA, United States
4.Department of Cardiology, First Affiliated Hospital, Xi'an Jiaotong University, Xian, China
5.Department of Pediatrics (Cardiology), Cardiovascular Institute and Wall Center for Pulmonary Vascular Diseases, Stanford University School of Medicine, Stanford, CA, United States
6.Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China
7.Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University, Xian, China
8.Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan
9.Warshel Institute for Computational Biology, School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, China
10.Department of Cardiology & Key Lab of Pulmonary Vascular Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Recommended Citation
GB/T 7714
Zhang, J.,He, Y.,Yan, X.et al. MicroRNA-483 amelioration of experimental pulmonary hypertension[J]. EMBO Molecular Medicine,2020.
APA Zhang, J., He, Y., Yan, X., Chen, S., He, M., .. & Shyy, J.Y.J. (2020). MicroRNA-483 amelioration of experimental pulmonary hypertension. EMBO Molecular Medicine.
MLA Zhang, J.,et al."MicroRNA-483 amelioration of experimental pulmonary hypertension".EMBO Molecular Medicine (2020).
Files in This Item:
File Name/Size DocType File Type Version Access License
MicroRNA-483 amelior(1476KB)Journal article--Published draftRestricted AccessCC BY-NC-SA
Related Services
Usage statistics
Google Scholar
Similar articles in Google Scholar
[Zhang, J.]'s Articles
[He, Y.]'s Articles
[Yan, X.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhang, J.]'s Articles
[He, Y.]'s Articles
[Yan, X.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhang, J.]'s Articles
[He, Y.]'s Articles
[Yan, X.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.